ImmunologyToday, vol. 6, No. 1, 1985

Useful guide to negotiating research agreements

Latin American Association of Immunology The Latin American Association of Immunology (ALAI) was founded during the First Argentinian Congress of Immunology in Buenos Aires, Argentina, June 23-29, 1984. At the constitution of the Association, immtmological societies from Argentina, Brazil, Chile and the United States were represented. Immunologists from Uruguay and Honduras were also present and support from the Mexican and Peruvian Societies of Immunology was received. The Association is a gathering of immunologists from Latin America who are interested in the progress of scientific research and technological development. Buenos Aires, Argentina, will be the headquarters for the period 1984-87. The Executive Committee is L.C. Girando Conesa (Argentina), president; Nelson F. Mendes (Brazil), second vice-president; A.B.

Mazzolli, secretary; C. Barrera, undersecretary; and Y. de Bonaparte, treasurer. The appointed foreign delegates are: O. Stutman, B. Frangione and M. Stadecker (North America); E. Falcoff and A. Roseto (France) and H. Besedovsky (Switzerland). The First Latin American Congress of Immunology will be held in Argentina in 1987. The objectives of the ALAI include the promotion of scientific meetings, exchange of investigators, programs for collaborative studies and publications, transfer of scientific and technological information, and the active participation of Latin America in the I.U.I.S. For more information please write to: Dr. Chris Giraudo Conesa, Presidente de ALAI, Las Heras 4081-14°8, (1425) Buenos Aires, Argentina

Now available from the Council for Chemical Research, the 'University-lndustty Ineraction: Guide to Developing Fundamental Research Agreements' is a 40-page manual aimed at simplifying what can be a formidable task. It discusses the various aspects of the typical university-industry research agreement and contains examples of actual agreements negotiated between universities and companies. Published by the Council for Chemical Research, Inc., P.O. Box AJ, Allentown, PA 18106, USA. Price US $7.00 (postage paid).

Fauci appointed NIAID director Anthony S. Fauci has been appointed to succeed Richard Krause as director of America's National Institute of Allergy and Infectious Diseases.

Human IL-2 reference reagent available Efforts to establish WHO-approved standards of interleukin 2 (IL-2) have now begun but will require several years for completion. In the interim, a reference reagent of J U R K A T IL-2 has been prepared in large quantities and is now available for calibrating in-house laboratory standards of human IL2. Investigators may request two lml vials of 1 000 units each per year. The IL-2 is stored at - 70°C and will be shipped to requestors by COD air express. The requestor will have to pay shipping charges, but the reagent itself is free. It can be requested by writing on organization letterhead to:

Dr Gary B. Thurman, NCI - Frederick Cancer Research Facility, Building 426, Room 1, FREDERICK, MD 21701 USA Tel: (301)695-1098 The Biological Response Modifiers Program of the Division of Cancer Treatment, National Cancer Institute, is assisting in this way the work of the IUIS Lyrnphokine Standardization Subcommittee (co chairmen: D. C. Dumonde, St Thomas Hospital, London SE1 7EH, U.K. or Dr B. W. Papermaster, Cancer Research Center, Columbia, Missouri 65205, USA, Tel. (314) 875-2255).

WHO committee report on rabies The W H O Expert Committee on Rabies met in Geneva in September, 1983 and has prepared its report as a self-contained document making new recommendations as well as incorporating parts of the previous report that do not require modification. The 100-page booklet, published as part of the WHO Technical Report Series, contains the collective views of an international group of experts on a wide range of issues concerning rabies. Topics discussed include diagnosis and treatment, prevention and vaccines, advances in research and control of rabies in wildlife. Reference material available and the exchange of information and training are

also covered, together with an outline of the step-by step organization of a national dog rabies control programme recommended by the Committee as an aid to Governments. The appendices include some useful addresses international institutes for technical co-operation in rabies control and centres of information exchange - and a list of selected literature on the subject. A comprehensive document containing advice and recommendations on many aspects of the field of rabies today. W H O ~Fech Report series, no 709. WHO, Distribution and Sales Services, 1211 Geneva, Su,~tzerland SFr. 9.00.

Dr Fauci, aged 43, has been chief of NIAID's Laboratory of Immunoregulation since 1980 and deputy clinical director of the institute since 1977. His clinical interests have included the effects on human immune responses of suppressive agents such as steroids and cyclophosphamide, and the value of these agents in the treatment of inflammatory and autoimmune disorders. In the past several years, Dr Fauci's laboratory has carried out basic studies on human lymphocyte subpopulations, particularly the activation, proliferation and differentiation of B lymphocytes in health and disease.

Latin American association of immunology.

Latin American association of immunology. - PDF Download Free
544KB Sizes 3 Downloads 6 Views